BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 26447530)

  • 1. The Tissue-Engineered Vascular Graft-Past, Present, and Future.
    Pashneh-Tala S; MacNeil S; Claeyssens F
    Tissue Eng Part B Rev; 2016 Feb; 22(1):68-100. PubMed ID: 26447530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Strategies for the Manufacture of Small Size Tissue Engineering Vascular Grafts.
    Carrabba M; Madeddu P
    Front Bioeng Biotechnol; 2018; 6():41. PubMed ID: 29721495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue engineered small-diameter vascular grafts.
    Schmedlen RH; Elbjeirami WM; Gobin AS; West JL
    Clin Plast Surg; 2003 Oct; 30(4):507-17. PubMed ID: 14621299
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Keshavarzian M; Meyer CA; Hayenga HN
    Tissue Eng Part C Methods; 2019 Nov; 25(11):641-654. PubMed ID: 31392930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression from stenosis to occlusion in the proximal native coronary artery after coronary artery bypass grafting.
    Tanaka A; Ishii H; Oshima H; Shibata Y; Tatami Y; Osugi N; Ota T; Kawamura Y; Suzuki S; Usui A; Murohara T
    Heart Vessels; 2016 Jul; 31(7):1056-60. PubMed ID: 26174429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of coronary artery bypass grafting on native coronary artery stenosis. Comparison of internal thoracic artery and saphenous vein grafts.
    Hamada Y; Kawachi K; Yamamoto T; Nakata T; Kashu Y; Watanabe Y; Sato M
    J Cardiovasc Surg (Torino); 2001 Apr; 42(2):159-64. PubMed ID: 11292927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current biofabrication methods for vascular tissue engineering and an introduction to biological textiles.
    Kawecki F; L'Heureux N
    Biofabrication; 2023 Mar; 15(2):. PubMed ID: 36848675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulation Strategies for the Successful Regeneration of a Tissue-Engineered Vascular Graft.
    Zhang F; King MW
    Adv Healthc Mater; 2022 Jun; 11(12):e2200045. PubMed ID: 35286778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for in vivo growth potential and vascular remodeling of tissue-engineered artery.
    Cho SW; Kim IK; Kang JM; Song KW; Kim HS; Park CH; Yoo KJ; Kim BS
    Tissue Eng Part A; 2009 Apr; 15(4):901-12. PubMed ID: 18783324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Review of Tissue-Engineered Vascular Grafts.
    Durán-Rey D; Crisóstomo V; Sánchez-Margallo JA; Sánchez-Margallo FM
    Front Bioeng Biotechnol; 2021; 9():771400. PubMed ID: 34805124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excellent patency and growth potential of internal mammary artery grafts in pediatric coronary artery bypass surgery. New evidence for a "live" conduit.
    Kitamura S; Seki T; Kawachi K; Morita R; Kawata T; Mizuguchi K; Kobayashi S; Fukutomi M; Nishii T; Kobayashi H
    Circulation; 1988 Sep; 78(3 Pt 2):I129-39. PubMed ID: 3261649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts.
    Desai ND; Cohen EA; Naylor CD; Fremes SE;
    N Engl J Med; 2004 Nov; 351(22):2302-9. PubMed ID: 15564545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractional flow reserve-guided coronary artery bypass grafting: can intraoperative physiologic imaging guide decision making?
    Ferguson TB; Chen C; Babb JD; Efird JT; Daggubati R; Cahill JM
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):824-835.e1. PubMed ID: 23915918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compositions Including Synthetic and Natural Blends for Integration and Structural Integrity: Engineered for Different Vascular Graft Applications.
    Shojaee M; Bashur CA
    Adv Healthc Mater; 2017 Jun; 6(12):. PubMed ID: 28371505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-engineered blood vessel graft produced by self-derived cells and allogenic acellular matrix: a functional performance and histologic study.
    Yang D; Guo T; Nie C; Morris SF
    Ann Plast Surg; 2009 Mar; 62(3):297-303. PubMed ID: 19240529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Progress in Vascular Engineering and Its Clinical Applications.
    Jouda H; Larrea Murillo L; Wang T
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication of tissue-engineered vascular grafts with stem cells and stem cell-derived vascular cells.
    Wang L; Hu J; Sorek CE; Chen EY; Ma PX; Yang B
    Expert Opin Biol Ther; 2016; 16(3):317-30. PubMed ID: 26560995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. History, progress and future challenges of artificial blood vessels: a narrative review.
    Hu K; Li Y; Ke Z; Yang H; Lu C; Li Y; Guo Y; Wang W
    Biomater Transl; 2022; 3(1):81-98. PubMed ID: 35837341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-Engineered Small Diameter Arterial Vascular Grafts from Cell-Free Nanofiber PCL/Chitosan Scaffolds in a Sheep Model.
    Fukunishi T; Best CA; Sugiura T; Shoji T; Yi T; Udelsman B; Ohst D; Ong CS; Zhang H; Shinoka T; Breuer CK; Johnson J; Hibino N
    PLoS One; 2016; 11(7):e0158555. PubMed ID: 27467821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of the Minimally Invasive Coronary Artery Bypass Grafting Angiographic Patency Study.
    Ruel M; Shariff MA; Lapierre H; Goyal N; Dennie C; Sadel SM; Sohmer B; McGinn JT
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):203-8. PubMed ID: 24183338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.